Related Experiment Videos
Bcl-2 does not require Raf kinase activity for its death-protective function
1Institute of Biochemistry, University of Fribourg, Rue du Musee 5, CH-1700 Fribourg.
Abstract:
It has been widely accepted that the oncogene product bcl-2 protects mammalian cells from programmed cell death (apoptosis). The molecules and signalling pathways upon which bcl-2 acts are, however, still ill-defined. Recently, bcl-2 was shown to interact with c-raf-1 in vitro. Furthermore, an active form of c-raf-1 delayed apoptosis induced by trophic factor deprivation and enhanced the death-suppressive function of bcl-2 when co-expressed. This has led to the hypothesis that bcl-2 communicates cell-death protection via a raf-dependent signal transduction pathway. Here we show, by various immunological and biochemical methods, that bcl-2 does not stably associate with c-raf-1 in cellular extracts prepared from fibroblasts before or after treatment with agents that induce apoptosis. Unexpectedly, bcl-2 function is entirely maintained, if not improved, when raf-dependent signalling is experimentally abrogated. In fact, bcl-2 allows the stable overexpression of a kinase-defective dominant-negative raf mutant that usually interferes with cell viability and/or proliferation. Our results indicate that bcl-2 does not require c-raf-1 kinase activity and an associated mitogen-activated protein kinase signalling pathway for its survival function. This property may be exploited to dissect cellular events that are dependent or independent of c-raf-1 kinase activity.
Insights
The oncogene bcl-2 (B-cell lymphoma 2) prevents cell death but does not require c-raf-1 kinase activity. This finding challenges the hypothesis that bcl-2 uses raf-dependent pathways for its survival function.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The oncogene bcl-2 (B-cell lymphoma 2) is known to inhibit apoptosis (programmed cell death) in mammalian cells.
- The precise molecular mechanisms and signaling pathways targeted by bcl-2 remain incompletely understood.
- Previous in vitro studies suggested bcl-2 interacts with c-raf-1, proposing a raf-dependent signaling pathway for bcl-2's death-suppressive function.
Purpose of the Study:
- To investigate the role of c-raf-1 kinase activity in mediating the anti-apoptotic function of bcl-2.
- To determine if bcl-2 stably associates with c-raf-1 in cellular extracts.
- To test the hypothesis that bcl-2 requires raf-dependent signal transduction for cell-death protection.
Main Methods:
- Immunological assays
- Biochemical methods
- Analysis of cellular extracts from fibroblasts
- Overexpression of kinase-defective raf mutants
Main Results:
- bcl-2 does not stably associate with c-raf-1 in cellular extracts, even after induction of apoptosis.
- The survival function of bcl-2 is maintained or enhanced when raf-dependent signaling is inhibited.
- bcl-2 can support the stable overexpression of a dominant-negative raf mutant that typically impairs cell viability.
Conclusions:
- bcl-2 does not require c-raf-1 kinase activity or the associated mitogen-activated protein kinase (MAPK) pathway for its cell survival function.
- These findings decouple bcl-2's anti-apoptotic role from raf-dependent signaling.
- This dissociation offers opportunities to dissect cellular events independently of c-raf-1 kinase activity.